Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

US Patent 10351534 · Granted Jul 16, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacy2023
N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors2021
Antimetastatic 2H-selenopheno[3,2-h]chromenes, synthesis thereof, and methods of2020
Genetically stable oncolytic RNA virus, method of manufacturing and use thereof2019
Genetically stable oncolytic RNA virus, method of manufacturing and use thereof2019
Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment 2018
Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment 2018
Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment 2018
Thieno [2,3-b] pyridines as multidrug resistance modulators2018
Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular di2017
Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular di2017
Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular di2017